Chugai Pharmaceutical Co., Ltd. (CHGCF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Chugai Pharmaceutical Co., Ltd.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
31.26
Weak
WeakModerateStrong
P/B Ratio
6.70
Weak
WeakModerateStrong
Earnings Yield
3.20%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
21.42%
Strong
WeakModerateStrong
Operating Margin
46.92%
Strong
WeakModerateStrong
Net Profit Margin
34.50%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
7.55%
Moderate
WeakModerateStrong
Net Income Growth
12.15%
Moderate
WeakModerateStrong
EPS Growth
12.16%
Moderate
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
4.23
Strong
WeakModerateStrong
Quick Ratio
3.56
Strong
WeakModerateStrong
Asset Turnover
0.51x
Moderate
WeakModerateStrong
Inventory Turnover
1.31x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
2.31%
Weak
WeakModerateStrong
EV / Free Cash Flow
41.95x
Weak
WeakModerateStrong
Net Debt / EBITDA
-0.68x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.013
Strong
WeakModerateStrong
Return on Invested Capital
20.83%
Strong
WeakModerateStrong
Cash Conversion Cycle
278.71 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CHGCF.
View Financial Statements